Stay updated on Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Sign up to get notified when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.

Latest updates to the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page
- ChecktodayChange DetectedThe page now displays Revision: v3.5.4 instead of v3.5.3, indicating an update to the page's revision label rather than any changes to the study content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's revision tag was updated from v3.5.2 to v3.5.3, indicating the page content has been updated to a newer revision.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedPage revision updated to v3.5.2, replacing the previous v3.5.0 revision.SummaryDifference0.0%

- Check36 days agoChange DetectedIQVIA Pty Ltd was added to the Collaborators list. The entry 'Iqvia Pty Ltd' was removed and reformatted with correct capitalization.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page now displays revision v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Depemokimab Clinical Trial in Severe Eosinophilic Asthma
Enter your email address, and we'll notify you when there's something new on the Depemokimab Clinical Trial in Severe Eosinophilic Asthma page.